Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), sold 187,480 shares at $1.62 ($289K) on 2019-09-20, disclosed to the SEC on 2019-09-24.
Open-market sale of $289k ONTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.62 | 75,119 | $122K | 42.1% |
| 2 | $1.62 | 75,119 | $122K | 42.1% |
| 3 | $1.23 | 37,242 | $46K | 15.8% |
| Total | $1.54 avg | 187,480 | $289K | 100% |
| Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-11 | $1K | — | Filing → |
| ONTX | SELL | 2019-09-09 | $15K | — | Filing → |